|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 564 active entries
55 Diamond Road
Phone: +44 (0) 28 9442 4213
Fax: +44 (0) 28 9445 2912
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Randox Pharma Services is a highly innovative global leader in clinical diagnostic manufacturing. We supply the world’s top Contract Research Organisations (CRO’s), Pharmaceutical and Biotech companies.
Over the past 3 decades Randox has built up operations in 145 countries. We have a strong R&D ethos with 20% of total annual revenue invested. We employ over 250 highly specialised scientists and our products are now used by over 100,000 customers.
Expertise you can trust in - from concept to completion
Randox Pharma Services are uniquely positioned to offer a full package from pre-clinical diagnostic solutions right through to the customised development of companion diagnostics.
We have built up unrivalled in-house technical expertise – be it in class-leading diagnostic, prognostic, predictive and CDx assay development and optimisation, multiplex protein nucleic acid arrays and analysers, clinical chemistry and immunoassay assays and analysers as well fully customised human and animal quality control sera and calibrators.
Randox is internationally recognised and trusted as the provider of the most accurate QC products available globally and operates the world’s largest PT/EQA scheme.
Biochip Array Technology – simply revolutionising clinical diagnostics
Randox has pioneered a revolutionary technology - Biochip Array Technology – a unique multiplexing method using ELISA methodology from a single sample. This platform is complemented by the evidence series of analysers which have transformed laboratory testing.
Randox Pharma services is your ideal companion for CDx development
Randox is engaged in companion diagnostic programs with a number of global biopharma companies. These include single analyte clinical chemistry based assays, multiplex pathogen detection, mutation, SNP and gene expression based arrays. We currently provide an impressive range of over 220 FDA cleared assays.
Our products have applications across all therapeutic areas
Randox offers a comprehensive range of over 400 biomarker assays for both routine and esoteric testing with relevance across all therapeutic area including; Oncology, Cardiovascular /Metabolic Disease, CNS, Immunoinflammation, Infection and Endocrinology with many more in development.
Randox Pharma Services is an experienced partner with ISO-accredited manufacturing facilities and highly specialised scientists. This enables us to provide a service and product tailored to the most demanding R&D project or clinical development programme.
For further information on the most complete biomarker package available or to discuss a potential collaboration, please visit www.randoxpharmaservices.com or contact the pharma services team on:
Tel: +44 (0) 28 9442 2413
Last update of this entry: September 25, 2014